Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

BACKGROUND: The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging. PURPOSE: In this study, we intend to analyze the value of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530434/
https://www.ncbi.nlm.nih.gov/pubmed/23300731
http://dx.doi.org/10.1371/journal.pone.0052638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530434/
https://www.ncbi.nlm.nih.gov/pubmed/23300731
http://dx.doi.org/10.1371/journal.pone.0052638

Ejemplares similares